Allogene Therapeutics, Inc.

Historical 13F Holders

Symbol
ALLO
CUSIP
019770106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 019770106 since 12/18/2024, largest first.

Filer % of Class Filed
Pfizer Inc. 13D/A 9.0% 2/13/2026
Event 11/6/2025
Citadel Securities GP LLC 13G
7.1% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 6.7% 10/27/2026
Event 9/30/2026
Frazier Life Sciences Public Fund, L.P. 13G/A
5.6% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
Chang David D 13G/A
4.9% 5/13/2026
Event 3/31/2026
FMR LLC 13G/A
4.9% 3/7/2025
Event 2/28/2025
State Street Corp 13G 4.7% 11/10/2026
Event 9/30/2026
Belldegrun Arie 13G/A
3.9% 8/7/2026
Event 6/30/2026
Citadel Advisors LLC 13G/A
2.8% 5/15/2026
Event 3/31/2026
Capital World Investors 13G/A 0% 11/13/2025
Event 9/30/2025
Lynx1 Capital Management LP 13G/A
0% 5/15/2026
Event 12/31/2025
TPG GP A, LLC 13D/A
0% 9/30/2026
Event 9/28/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 199 304 M $487M
2026 Q2 210 313 M $652M
2026 Q1 211 185 M $446M
2025 Q4 173 163 M $223M
2025 Q3 172 162 M $201M
2025 Q2 161 184 M $208M
2025 Q1 172 197 M $302M
2024 Q4 176 189 M $402M
2024 Q3 157 164 M $460M
2024 Q2 176 165 M $385M
2024 Q1 162 131 M $586M
2023 Q4 172 122 M $392M
2023 Q3 156 130 M $413M
2023 Q2 172 133 M $663M
2023 Q1 179 118 M $582M
2022 Q4 170 111 M $701M
2022 Q3 194 106 M $1.15B
2022 Q2 162 101 M $1.15B
2022 Q1 181 91.7 M $837M
2021 Q4 179 85.8 M $1.28B
2021 Q3 170 88.0 M $2.26B
2021 Q2 187 86.3 M $2.25B
2021 Q1 173 88.4 M $3.12B
2020 Q4 166 89.4 M $2.26B
2020 Q3 164 85.2 M $3.21B
2020 Q2 177 88.7 M $3.80B
2020 Q1 116 73.7 M $1.44B
2019 Q4 119 71.6 M $1.86B
2019 Q3 98 68.7 M $1.87B
2019 Q2 97 68.9 M $1.85B
2019 Q1 90 65.4 M $1.88B
2018 Q4 82 62.7 M $1.68B
2016 Q1 1 4.03 k $115k